Concepedia

Siddesh V. Hartimath

SV

Statistics

Publications

23

Citations

579

H-Index

15

Active since

2013

Affiliations

Agency for Science, Technology and Research(Current)

National University of Singapore

Singapore Bioimaging Consortium

Singapore Immunology Network

University of Saskatchewan

Siddesh V. Hartimath is an author at Agency for Science, Technology and Research specializing in medicine, molecular imaging, and oncology.

Publications per year

2013–2024

23

Publications

23

Lung endothelial cell antigen cross-presentation to CD8+T cells drives malaria-associated lung injury

Carla Claser, Samantha Yee Teng Nguee, Akhila Balachander et al. · Nature Communications · 2019 · 80 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Noninvasive monitoring of cancer therapy induced activated T cells using [<sup>18</sup>F]FB-IL-2 PET imaging

Siddesh V. Hartimath, Oana Draghiciu, Stephanie van de Wall et al. · OncoImmunology · 2016 · 59 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Evaluation of <i>N</i>-[<sup>11</sup>C]Methyl-AMD3465 as a PET Tracer for Imaging of CXCR4 Receptor Expression in a C6 Glioma Tumor Model

Siddesh V. Hartimath, Aren van Waarde, Rudi Dierckx et al. · Molecular Pharmaceutics · 2014 · 35 citations

Medicine, Nuclear Medicine, Pharmacology +17

Haploinsufficiency of CYP8B1 associates with increased insulin sensitivity in humans

Raphaël Chèvre, Maria Corlianò, Blake J. Cochran et al. · Journal of Clinical Investigation · 2022 · 35 citations · Full text

Medicine, Genetics, Molecular Genetics +17

<sup>111</sup>In- and <sup>225</sup>Ac-Labeled Cixutumumab for Imaging and α-Particle Radiotherapy of IGF-1R Positive Triple-Negative Breast Cancer

V. Raja Solomon, Elahe Alizadeh, Wendy Bernhard et al. · Molecular Pharmaceutics · 2019 · 33 citations

Medicine, Molecular Pharmaceutics, Oncology +17

1–5 of 23